Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update: current management issues in malignant melanoma.

Paola Queirolo1, Mirko Acquati, John M Kirkwood

  • 1Department of Medical Oncology A, National Institute for Cancer Research, Genoa, Italy.

Melanoma Research
|September 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Nature communications·2026
Same author

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

European journal of cancer (Oxford, England : 1990)·2026
Same author

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Type 1 Diabetes and Multiple Sclerosis Share General Autoimmunity Genetic Variation.

Genes·2026
Same author

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Ecancermedicalscience·2026
Same author

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Dissecting cellular heterogeneity across two ocular melanoma subtypes by single-cell RNA sequencing.

Melanoma research·2026
Same journal

An online cutaneous melanoma risk screen tool.

Melanoma research·2026
Same journal

The role of circulating tumor DNA in the management of melanoma: a literature review.

Melanoma research·2026
Same journal

Schisandrin C suppresses melanoma growth and metastasis through modulation of Rap1-related and phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin signaling pathways.

Melanoma research·2026
Same journal

Factors to consider in a primary care setting when using convolutional neural network tools for melanoma diagnostics: a retrospective analysis of images and patient characteristics.

Melanoma research·2026
Same journal

Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.

Melanoma research·2026
See all related articles

Melanoma incidence is rising, and surgery alone risks relapse for advanced cases. This review examines adjuvant trials and chemotherapy, including fotemustine, for metastatic melanoma management.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma incidence has shown a continuous increase over the past decade.
  • Surgery is the primary treatment for melanoma, but high relapse rates persist for patients with thick lesions or regional metastatic lymph nodes.
  • There is currently no established standard therapy or consensus among oncologists for managing these high-risk melanoma patients.

Purpose of the Study:

  • To review the current management strategies for melanoma.
  • To analyze past and ongoing adjuvant clinical trials in melanoma.
  • To discuss the role of chemotherapy, specifically fotemustine, in treating metastatic melanoma.

Main Methods:

  • Literature review of completed and open adjuvant melanoma trials.

Related Experiment Videos

  • Discussion of chemotherapy options for metastatic melanoma.
  • Focus on the application and efficacy of fotemustine.

    • Main Results:

    • The review synthesizes data from various adjuvant trials, highlighting treatment outcomes and limitations.
    • The article evaluates the current landscape of chemotherapy for metastatic melanoma.
    • Fotemustine is discussed as a potential chemotherapeutic agent.

    Conclusions:

    • Adjuvant therapy and chemotherapy remain critical areas of investigation for improving melanoma patient outcomes.
    • Further research and clinical trials are needed to establish optimal treatment protocols for high-risk melanoma.
    • Fotemustine represents one avenue of exploration in the chemotherapeutic management of metastatic melanoma.